Asset Details
Do you wish to reserve the book?
Chylothorax in Uncommon Contexts: Pulmonary Tuberculosis and Mantle Cell Lymphoma
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Chylothorax in Uncommon Contexts: Pulmonary Tuberculosis and Mantle Cell Lymphoma
Do you wish to request the book?
Chylothorax in Uncommon Contexts: Pulmonary Tuberculosis and Mantle Cell Lymphoma
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Chylothorax in Uncommon Contexts: Pulmonary Tuberculosis and Mantle Cell Lymphoma
2025
Overview
Chylothorax, characterised by the accumulation of chyle in the pleural space, is a rare yet clinically significant condition. This lymphatic fluid, rich in fats absorbed from the intestine, can be caused by various factors including trauma, malignancy, and tuberculosis (TB). Traumatic causes, particularly iatrogenic procedures, account for a significant proportion of cases, followed by rare etiologies like malignancies such as lymphoma, and less commonly, tuberculosis. In the first two cases, the patient was diagnosed with tuberculosis during evaluation for chylothorax; however, in the third case, the patient developed chylothorax as a complication of mantle cell lymphoma (MCL). Two male patients, aged 43 and 45, presented with respiratory symptoms and milky pleural effusions (triglycerides > 180 mg/dL). In both, bronchoalveolar lavage confirmed rifampicin‐sensitive TB. Both patients responded to anti‐tubercular therapy and dietary modification. A 69‐year‐old male with a history of non‐Hodgkin's lymphoma developed chylothorax (triglycerides 286 mg/dL) and lymphadenopathy; imaging and biopsy confirmed MCL. He responded to chemotherapy. This series underscores the importance of considering uncommon causes of chylothorax during evaluation and tailoring treatment based on specific etiologies. We present a series of three cases, which emphasises the diverse causes and treatment of chylothorax.
